Seed VC · France

Kurma Partners

Active

What they invest in

We build companies by working with leading European research centers to transform disruptive scientific discoveries into cutting-edge medicines or medical devices to diagnose and treat patients with severe diseases with high unmet medical need.

Who they back

DeepTechHealthtechBiotechSeed

Business models

biotech_therapeutics, deeptech_ip

Customer segments

Researchers, Healthcare providers, Patients

Geography

Europe, Germany, France

Recent investments

  • Adcytherix
  • Alveus Therapeutics
  • Amolyt Pharma

+ 3 more deals. Score your deck to see the full investment history.

The people who write checks

12 partners on file at Kurma Partners, with the firm's email pattern for cold outreach. Score your deck (free, 30 seconds) to unlock direct contact for this firm and 47,000+ others.

We never publish partner emails directly. Score your deck to unlock contacts for the firms ranked as best-fit.

Why this firm matters for fundraising founders

Kurma Partners writes first institutional checks where the founder + early product matter more than traction. The seed market is the most dispersed segment of venture; matching to thesis (sector, stage, geography) is where most cold outreach succeeds or fails. VC Boom tracks Kurma Partners alongside 47,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.

At a glance

Based in
France
Last known deal
Sep 2024
Portfolio last checked
Oct 6, 2026
Website
www.kurmapartners.com/en ↗

Other firms investing in DeepTech

See all investors

Is Kurma Partners the right fit for your deck?

Drop your pitch. VC Boom scores it on the 8 dimensions VCs read for and ranks the 47,000+ active investors in the database by fit. Kurma Partners is one of them, and we'll tell you exactly where they sit in your top 100.